2023 Korean Society of Echocardiography position paper for diagnosis and management of valvular heart disease, part I: aortic valve disease

키워드

참고문헌 (121)

1. Otto CM, "2020 ACC", AHA guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology, Circulation, pp.2021, 143[DOI]
2. Vahanian A, "2021 ESC", EACTS guidelines for the management of valvular heart disease, 2022, pp.43, 561~632
3. Iung B, "Contemporary presentation and management of valvular heart disease : the EURObservational Research Programme valvular heart disease II survey", Circulation, 140, pp.1156~1169 (2019)
4. Yadgir S, "Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990–2017", Circulation, 141, pp.1670~1680 (2020)
5. d’Arcy JL, "Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people : the OxVALVE Population Cohort Study", Eur Heart J, 37, pp.3515~3522 (2016)
6. Masri A, "Contemporary natural history of bicuspid aortic valve disease : a systematic review", Heart, 103, pp.1323~1330 (2017)
7. Choi YJ, "Epidemiologic profile of patients with valvular heart disease in Korea : a nationwide hospital-based registry study", J Cardiovasc Imaging, 31, pp.51~61 (2023)
8. Kang DH, "Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis", Circulation, 121, pp.1502~1509 (2010)
9. Kang DH, "Early surgery or conservative care for asymptomatic aortic stenosis", N Engl J Med, 382, pp.111~119 (2020)
10. Baumgartner H, "Recommendations on the echocardiographic assessment of aortic valve stenosis : a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography", J Am Soc Echocardiogr, 30, pp.372~392 (2017)
11. Tastet L, "Staging cardiac damage in patients with asymptomatic aortic valve stenosis", J Am Coll Cardiol, 74, pp.550~563 (2019)
12. Otto CM, "Aortic-valve stenosis : from patients at risk to severe valve obstruction", N Engl J Med, 371, pp.744~756 (2014)
13. Remenyi B, "Valvular aspects of rheumatic heart disease", Lancet, 387, pp.1335~1346 (2016)
14. Hachicha Z, "Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival", Circulation, 115, pp.2856~2864 (2007)
15. Pibarot P, "Improving assessment of aortic stenosis", J Am Coll Cardiol, 60, pp.169~180 (2012)
16. Briand M, "Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis : implications for diagnosis and treatment", J Am Coll Cardiol, 46, pp.291~298 (2005)
17. Clavel MA, "Outcome of patients with aortic stenosis, small valve area, and lowflow, low-gradient despite preserved left ventricular ejection fraction", J Am Coll Cardiol, 60, pp.1259~1267 (2012)
18. Minners J, "Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis", Eur Heart J, 29, pp.1043~1048 (2008)
19. Clavel MA, "Predictors of outcomes in low-flow, low-gradient aortic stenosis : results of the multicenter TOPAS Study", Circulation, 118, pp.S234~S242 (2008)
20. Nishimura RA, "Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function : the clinical utility of the dobutamine challenge in the catheterization laboratory", Circulation, 106, pp.809~813 (2002)
21. Pibarot P, "Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction", J Am Coll Cardiol, 60, pp.1845~1853 (2012)
22. Jander N, "Outcome of patients with low-gradient"severe"aortic stenosis and preserved ejection fraction", Circulation, 123, pp.887~895 (2011)
23. Eleid MF, "Survival by stroke volume index in patients with low-gradient normal EF severe aortic stenosis", Heart, 101, pp.23~29 (2015)
24. Lee PH, "Impact of significant mitral regurgitation on assessing the severity of aortic stenosis", J Am Soc Echocardiogr, 31, pp.26~33 (2018)
25. Mehrotra P, "Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis", Eur Heart J, 34, pp.1906~1914 (2013)
26. Rusinaru D, "Relation of dimensionless index to long-term outcome in aortic stenosis with preserved LVEF", JACC Cardiovasc Imaging, 8, pp.766~775 (2015)
27. Vollema EM, "Association of left ventricular global longitudinal strain with asymptomatic severe aortic stenosis : natural course and prognostic value", JAMA Cardiol, 3, pp.839~847 (2018)
28. Magne J, "Distribution and prognostic significance of left ventricular global longitudinal strain in asymptomatic significant aortic stenosis : an individual participant data meta-analysis", JACC Cardiovasc Imaging, 12, pp.84~92 (2019)
29. Bergler-Klein J, "Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis", Circulation, 109, pp.2302~2308 (2004)
30. Clavel MA, "B-type natriuretic peptide clinical activation in aortic stenosis : impact on long-term survival", J Am Coll Cardiol, 63, pp.2016~2025 (2014)
31. Maréchaux S, "Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis", Eur Heart J, 31, pp.1390~1397 (2010)
32. Saeed S, "Exercise testing in patients with asymptomatic moderate or severe aortic stenosis", Heart, 104, pp.1836~1842 (2018)
33. Atterhog JH, "Exercise testing : a prospective study of complication rates", Am Heart J, 98, pp.572~579 (1979)
34. Clavel MA, "Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis : results of an international registry study", J Am Coll Cardiol, 64, pp.1202~1213 (2014)
35. Pawade T, "Computed tomography aortic valve calcium scoring in patients with aortic stenosis", Circ Cardiovasc Imaging, 11, pp.e007146~ (2018)
36. Borger MA, "The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy : full online-only version", J Thorac Cardiovasc Surg, 156, pp.e41~e74 (2018)
37. Everett RJ, "Extracellular myocardial volume in patients with aortic stenosis", J Am Coll Cardiol, 75, pp.304~316 (2020)
38. Nitsche C, "Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis", J Am Coll Cardiol, 77, pp.128~139 (2021)
39. Park SJ, "Assessment of myocardial fibrosis using multimodality imaging in severe aortic stenosis : comparison with histologic fibrosis", JACC Cardiovasc Imaging, 12, pp.109~119 (2019)
40. Kwak S, "Markers of myocardial damage predict mortality in patients with aortic stenosis", J Am Coll Cardiol, 78, pp.545~558 (2021)
41. Nishimura RA, "Hemodynamics in the cardiac catheterization laboratory of the 21st century", Circulation, 125, pp.2138~2150 (2012)
42. Dekany G, "The prognostic value of immediate post-TAVI hemodynamic evaluation is superior to aortography and transoesophageal echocardiography in predicting patient survival", Int J Cardiol, 329, pp.153~161 (2021)
43. Cosmi JE, "The risk of the development of aortic stenosis in patients with"benign"aortic valve thickening", Arch Intern Med, 162, pp.2345~2347 (2002)
44. Rahimi K, "Elevated blood pressure and risk of aortic valve disease : a cohort analysis of 5. 4 million UK adults", Eur Heart J, 39, pp.3596~3603 (2018)
45. Nielsen OW, "Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis : the simvastatin ezetimibe in aortic stenosis study(SEAS)", Circulation, 134, pp.455~468 (2016)
46. Rossebø AB, "Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis", N Engl J Med, 359, pp.1343~1356 (2008)
47. Cowell SJ, "A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis", N Engl J Med, 352, pp.2389~2397 (2005)
48. Chan KL, "Effect of lipid lowering with rosuvastatin on progression of aortic stenosis : results of the aortic stenosis progression observation : measuring effects of rosuvastatin(ASTRONOMER)trial", Circulation, 121, pp.306~314 (2010)
49. Lee W, "Longterm prognosis of mild to moderate aortic stenosis and coronary artery disease", J Korean Med Sci, 36, pp.e47~ (2021)
50. Inohara T, "Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement", JAMA, 320, pp.2231~2241 (2018)
51. Ochiai T, "Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation", Heart, 104, pp.644~651 (2018)
52. Pawade TA, "Effect of denosumab or alendronic acid on the progression of aortic stenosis : a double-blind randomized controlled trial", Circulation, 143, pp.2418~2427 (2021)
53. Lee S, "Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis", Heart, 106, pp.1824~1831 (2020)
54. Kumar A, "Meta-analysis of early intervention versus conservative management for asymptomatic severe aortic stenosis", Am J Cardiol, 138, pp.85~91 (2021)
55. Gahl B, "Natural history of asymptomatic severe aortic stenosis and the association of early intervention with outcomes : a systematic review and meta-analysis", JAMA Cardiol, 5, pp.1102~1112 (2020)
56. Wojnarski CM, "Commentary : evidence is mounting for early intervention in asymptomatic severe aortic stenosis", J Thorac Cardiovasc Surg, 163, pp.1790~1791 (2022)
57. Ennezat PV, "Watchful waiting care or early intervention in asymptomatic severe aortic stenosis : where we are", Arch Cardiovasc Dis, 114, pp.59~72 (2021)
58. Banovic M, "Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis : the AVATAR trial", Circulation, 145, pp.648~658 (2022)
59. Bing R, "Rationale and design of the randomized, controlled Early Valve Replacement Guided by Biomarkers of Left Ventricular Decompensation in Asymptomatic Patients with Severe Aortic Stenosis(EVOLVED)trial", Am Heart J, 212, pp.91~100 (2019)
60. Badiani S, "what is it and when should we intervene?", Interv Cardiol, 16, pp.e09~ (2021)
61. Everett RJ, "Timing of intervention in aortic stenosis : a review of current and future strategies", Heart, 104, pp.2067~2076 (2018)
62. Lancellotti P, "Timing of intervention in aortic stenosis", N Engl J Med, 382, pp.191~193 (2020)
63. Ito S, "Prognostic risk stratification of patients with moderate aortic stenosis", J Am Soc Echocardiogr, 34, pp.248~256 (2021)
64. Jean G, "Moderate aortic stenosis in patients with heart failure and reduced ejection fraction", J Am Coll Cardiol, 77, pp.2796~2803 (2021)
65. Cormican DS, "The dilemma of moderate aortic stenosis in patients with heart failure and reduced ejection fraction : are we waiting too long to intervene, or should we wait for more evidence?", J Cardiothorac Vasc Anesth, 36, pp.15~17 (2022)
66. Chikwe J, "Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years", JAMA, 313, pp.1435~1442 (2015)
67. McClure RS, "Late outcomes comparison of nonelderly patients with stented bioprosthetic and mechanical valves in the aortic position : a propensity-matched analysis", J Thorac Cardiovasc Surg, 148, pp.1931~1939 (2014)
68. Chiang YP, "Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years", JAMA, 312, pp.1323~1329 (2014)
69. Kaneko T, "Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old", J Thorac Cardiovasc Surg, 147, pp.117~126 (2014)
70. Buratto E, "Improved survival after the ross procedure compared with mechanical aortic valve replacement", J Am Coll Cardiol, 71, pp.1337~1344 (2018)
71. Tuzcu EM, "Transcatheter aortic valve replacement of failed surgically implanted bioprostheses : the STS", ACC registry, 2018, pp.72, 370~382
72. Ye J, "Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves : an 8-year single-center experience", JACC Cardiovasc Interv, 8, pp.1735~1744 (2015)
73. Dvir D, "Transcatheter aortic valve implantation in failed bioprosthetic surgical valves", JAMA, 312, pp.162~170 (2014)
74. Leon MB, "Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery", N Engl J Med, 363, pp.1597~1607 (2010)
75. Smith CR, "Transcatheter versus surgical aortic-valve replacement in high-risk patients", N Engl J Med, 364, pp.2187~2198 (2011)
76. Leon MB, "Transcatheter or surgical aortic-valve replacement in intermediate-risk patients", N Engl J Med, 374, pp.1609~1620 (2016)
77. Mack MJ, "Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients", N Engl J Med, 380, pp.1695~1705 (2019)
78. Fu J, "Transcatheter versus surgical aortic valve replacement in low and intermediate risk patients with severe aortic stenosis : systematic review and meta-analysis of randomized controlled trials and propensity score matching observational studies", J Thorac Dis, 11, pp.1945~1962 (2019)
79. Reardon MJ, "Surgical or transcatheter aortic-valve replacement in intermediate-risk patients", N Engl J Med, 376, pp.1321~1331 (2017)
80. Thyregod HG, "Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis : 1-year results from the all-comers NOTION randomized clinical trial", J Am Coll Cardiol, 65, pp.2184~2194 (2015)
81. Jørgensen TH, "Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement", Eur Heart J, 42, pp.2912~2919 (2021)
82. Mentias A, "Long-term outcomes in patients with aortic regurgitation and preserved left ventricular ejection fraction", J Am Coll Cardiol, 68, pp.2144~2153 (2016)
83. Yang LT, "Outcomes in chronic hemodynamically significant aortic regurgitation and limitations of current guidelines", J Am Coll Cardiol, 73, pp.1741~1752 (2019)
84. de Meester C, "Do guideline-based indications result in an outcome penalty for patients with severe aortic regurgitation?", JACC Cardiovasc Imaging, 12, pp.2126~2138 (2019)
85. Yang LT, "Predictors of progression in patients with stage B aortic regurgitation", J Am Coll Cardiol, 74, pp.2480~2492 (2019)
86. Yoon SH, "Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis", J Am Coll Cardiol, 69, pp.2579~2589 (2017)
87. Forrest JK, "Transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valves from the STS", ACC TVT registry, 2020, pp.13, 1749~1759
88. Song S, "Progression and outcomes of non-dysfunctional bicuspid aortic valve : longitudinal data from a large Korean bicuspid aortic valve registry", Front Cardiovasc Med, 7, pp.603323~ (2020)
89. Kim MS, "Frequency and clinical associating factors of valvular heart disease in asymptomatic Korean adults", Sci Rep, 9, pp.16741~ (2019)
90. Sun BJ, "Clinical characteristics of Korean patients with bicuspid aortic valve who underwent aortic valve surgery", Korean Circ J, 48, pp.48~58 (2018)
91. Jeong H, "Prevalence, characteristics, and clinical significance of concomitant cardiomyopathies in subjects with bicuspid aortic valves", Yonsei Med J, 60, pp.816~823 (2019)
92. Lee SY, "Factors determining aortic valve dysfunction in Korean subjects with a bicuspid aortic valve", Am J Cardiol, 119, pp.2049~2055 (2017)
93. Yu CW, "Trends and outcomes of transcatheter aortic valve implantation(TAVI)in Korea : the results of the first cohort of Korean TAVI registry", Korean Circ J, 48, pp.382~394 (2018)
94. Kim H, "Clinical outcomes of transcatheter aortic valve implantation for native aortic valves in patients with low coronary heights", Yonsei Med J, 62, pp.209~214 (2021)
95. Lee CH, "Risk factors for closure failure following percutaneous transfemoral transcatheter aortic valve implantation", Ann Vasc Surg, 66, pp.406~414 (2020)
96. Kim C, "Aortic stenosis and transcatheter aortic valve implantation : current status and future directions in Korea", Korean Circ J, 49, pp.283~297 (2019)
97. Kim C, "Good patients make favorable clinical outcome : K-TAVI registry reports", Korean Circ J, 48, pp.427~429 (2018)
98. Iung B, "Epidemiology of acquired valvular heart disease", Can J Cardiol, 30, pp.962~970 (2014)
99. Maurer G, "Aortic regurgitation", Heart, 92, pp.994~1000 (2006)
100. Flint N, "Aortic regurgitation", Curr Cardiol Rep, 21, pp.65~ (2019)
101. Cho SH, "Preoperative indexed left ventricular dimensions to predict early recovery of left ventricular function after aortic valve replacement for chronic aortic regurgitation", Circ J, 74, pp.2340~2345 (2010)
102. Kim MS, "Prognostic markers and long-term outcomes after aortic valve replacement in patients with chronic aortic regurgitation", J Am Heart Assoc, 9, pp.e018292~ (2020)
103. Medvedofsky D, "2D and 3D echocardiography-derived indices of left ventricular function and shape : relationship with mortality", JACC Cardiovasc Imaging, 11, pp.1569~1579 (2018)
104. Myerson SG, "Aortic regurgitation quantification using cardiovascular magnetic resonance : association with clinical outcome", Circulation, 126, pp.1452~1460 (2012)
105. Goffinet C, "Comprehensive assessment of the severity and mechanism of aortic regurgitation using multidetector CT and MR", Eur Radiol, 20, pp.326~336 (2010)
106. Klodas E, "Optimizing timing of surgical correction in patients with severe aortic regurgitation : role of symptoms", J Am Coll Cardiol, 30, pp.746~752 (1997)
107. Dujardin KS, "Mortality and morbidity of aortic regurgitation in clinical practice A long-term follow-up study", Circulation, 99, pp.1851~1857 (1999)
108. Chaliki HP, "Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function", Circulation, 106, pp.2687~2693 (2002)
109. Kaneko T, "Aortic regurgitation with markedly reduced left ventricular function is not a contraindication for aortic valve replacement", Ann Thorac Surg, 102, pp.41~47 (2016)
110. Tornos P, "Long-term outcome of surgically treated aortic regurgitation : influence of guideline adherence toward early surgery", J Am Coll Cardiol, 47, pp.1012~1017 (2006)
111. Forman R, "Prognostic significance of preoperative left ventricular ejection fraction and valve lesion in patients with aortic valve replacement", Am J Cardiol, 45, pp.1120~1125 (1980)
112. Tornos MP, "Clinical outcome of severe asymptomatic chronic aortic regurgitation : a long-term prospective follow-up study", Am Heart J, 130, pp.333~339 (1995)
113. Turk R, "Survival benefit of aortic valve replacement in older patients with asymptomatic chronic severe aortic regurgitation", Ann Thorac Surg, 89, pp.731~737 (2010)
114. Park HW, "Effect of preoperative ejection fraction, left ventricular systolic dimension and hemoglobin level on survival after aortic valve surgery in patients with severe chronic aortic regurgitation", Am J Cardiol, 109, pp.1782~1786 (2012)
115. Amano M, "Pre-and postoperative predictors of long-term prognosis after aortic valve replacement for severe chronic aortic regurgitation", Circ J, 80, pp.2460~2467 (2016)
116. Sambola A, "Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation", Am Heart J, 155, pp.1114~1120 (2008)
117. Boodhwani M, "Repair-oriented classification of aortic insufficiency : impact on surgical techniques and clinical outcomes", J Thorac Cardiovasc Surg, 137, pp.286~294 (2009)
118. Davierwala PM, "Aortic valve repair versus replacement in bicuspid aortic valve disease", J Heart Valve Dis, 12, pp.679~686 (2003)
119. Minakata K, "Is repair of aortic valve regurgitation a safe alternative to valve replacement?", J Thorac Cardiovasc Surg, 127, pp.645~653 (2004)
120. Aicher D, "Valve configuration determines long-term results after repair of the bicuspid aortic valve", Circulation, 123, pp.178~185 (2011)
121. Pettersson GB, "Toward predictable repair of regurgitant aortic valves : a systematic morphology-directed approach to bicommissural repair", J Am Coll Cardiol, 52, pp.40~49 (2008)

관련 논문AI추천